companydata.dkCAND.PHARM. POVL M. ASSENS FOND: Financial statements 2022
CVR: 14536604
CAND.PHARM. POVL M. ASSENS FOND (CVR 14536604) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -3,324,757 compared with DKK 7,306,072 the year before. Equity amounted to DKK 101,669,796. The solvency ratio was 96.8%. The company had 47 employees in the financial year.
- Profit/Loss
- -3,324,757 kr.
- Equity
- 101,669,796 kr.
- Total Assets
- 105,018,045 kr.
- Employees
- 47
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -3.3 mio. | 101.7 mio. | 47 |
| 2021 | 0 | 0 | 7.3 mio. | 106.1 mio. | 41 |
| 2020 | 0 | 0 | 145 t. | 101.2 mio. | 37 |
| 2019 | 0 | 0 | 4.9 mio. | 102.9 mio. | 36 |
| 2018 | 0 | 0 | -1.7 mio. | 98.9 mio. | 36 |
Keep an eye on CAND.PHARM. POVL M. ASSENS FOND
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 7,306,072.
About CAND.PHARM. POVL M. ASSENS FOND
CAND.PHARM. POVL M. ASSENS FOND is a Danish company of the type Erhvervsdrivende fond based in Glostrup, founded in 1999. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 13,153,000 compared with DKK 11,790,112 the year before. Equity amounted to DKK 128,614,000.